2cureX AB (publ) (STO:2CUREX)
Sweden · Delayed Price · Currency is SEK 1.872
+0.072 (4.00%)
Jul 24, 2026, 4:23 PM CET
2cureX AB Market Cap
2cureX AB has a market cap or net worth of 59.72 million as of July 24, 2026. Its market cap has decreased by -19.08% in one year.
Market Cap
59.72M
Enterprise Value
n/a
Revenue
1.98M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.87
ChartMarket Cap Chart
Since November 24, 2017, 2cureX AB's market cap has decreased from 83.32M to 59.72M, a decrease of -28.32%. That is a compound annual growth rate of -3.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 59.72M | 362.86% |
| Dec 30, 2025 | 12.90M | 73.70% |
| Dec 30, 2024 | 7.43M | -79.00% |
| Dec 29, 2023 | 35.38M | -75.34% |
| Dec 30, 2022 | 143.46M | -51.13% |
| Dec 30, 2021 | 293.59M | 19.49% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Nov 24, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| OncoZenge AB | 100.44M |
| Annexin Pharmaceuticals AB | 88.24M |
| Spago Nanomedical AB | 75.75M |
| AcouSort AB | 75.13M |
| Ascelia Pharma AB | 67.97M |
| Pila Pharma AB | 57.79M |
| Modus Therapeutics Holding AB | 43.66M |
| Fluicell AB | 43.13M |